951 related articles for article (PubMed ID: 10495135)
1. Effects of 16 weeks of treatment with tibolone on bone mass and bone mechanical and histomorphometric indices in mature ovariectomized rats with established osteopenia on a low-calcium diet.
Yoshitake K; Yokota K; Kasugai Y; Kagawa M; Sukamoto T; Nakamura T
Bone; 1999 Sep; 25(3):311-9. PubMed ID: 10495135
[TBL] [Abstract][Full Text] [Related]
2. Effects of tibolone (Org OD14) treatment for 3 months on ovariectomy-induced osteopenia in 8-month-old rats on a low-calcium diet: preventive testing for 3 months.
Kasugai Y; Ikegami A; Matsuo K; Ohashi M; Sukamoto T; Hosoi T; Ouchi Y; Orimo H
Bone; 1998 Feb; 22(2):119-24. PubMed ID: 9477234
[TBL] [Abstract][Full Text] [Related]
3. Effect of 16 months of treatment with tibolone on bone mass, turnover, and biomechanical quality in mature ovariectomized rats.
Ederveen AG; Spanjers CP; Quaijtaal JH; Kloosterboer HJ
J Bone Miner Res; 2001 Sep; 16(9):1674-81. PubMed ID: 11547837
[TBL] [Abstract][Full Text] [Related]
4. Tibolone exerts its protective effect on trabecular bone loss through the estrogen receptor.
Ederveen AG; Kloosterboer HJ
J Bone Miner Res; 2001 Sep; 16(9):1651-7. PubMed ID: 11547834
[TBL] [Abstract][Full Text] [Related]
5. 1alpha-hydroxyvitamin D2 is less toxic but not bone selective relative to 1alpha-hydroxyvitamin D3 in ovariectomized rats.
Weber K; Goldberg M; Stangassinger M; Erben RG
J Bone Miner Res; 2001 Apr; 16(4):639-51. PubMed ID: 11315991
[TBL] [Abstract][Full Text] [Related]
6. The effects of nandrolone decanoate on bone mass and metabolism in ovariectomized rats with osteopenia.
Li X; Takahashi M; Kushida K; Shimizu S; Hoshino H; Suzuki M; Inoue T
J Bone Miner Metab; 2000; 18(5):258-63. PubMed ID: 10959614
[TBL] [Abstract][Full Text] [Related]
7. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
[TBL] [Abstract][Full Text] [Related]
8. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
[TBL] [Abstract][Full Text] [Related]
9. Long-term treatment with eldecalcitol (1α, 25-dihydroxy-2β- (3-hydroxypropyloxy) vitamin D3) suppresses bone turnover and leads to prevention of bone loss and bone fragility in ovariectomized rats.
Takeda S; Smith SY; Tamura T; Saito H; Takahashi F; Samadfam R; Haile S; Doyle N; Endo K
Calcif Tissue Int; 2015 Jan; 96(1):45-55. PubMed ID: 25467010
[TBL] [Abstract][Full Text] [Related]
10. 1alpha-hydroxyvitamin D2 partially dissociates between preservation of cancellous bone mass and effects on calcium homeostasis in ovariectomized rats.
Erben RG; Bante U; Birner H; Stangassinger M
Calcif Tissue Int; 1997 May; 60(5):449-56. PubMed ID: 9115163
[TBL] [Abstract][Full Text] [Related]
11. A new vitamin D analog, 2MD, restores trabecular and cortical bone mass and strength in ovariectomized rats with established osteopenia.
Ke HZ; Qi H; Crawford DT; Simmons HA; Xu G; Li M; Plum L; Clagett-Dame M; DeLuca HF; Thompson DD; Brown TA
J Bone Miner Res; 2005 Oct; 20(10):1742-55. PubMed ID: 16160732
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic effects of 1,24,25-trihydroxyvitamin D3 on ovariectomy-induced cancellous bone loss in the rat.
Erben RG; Bante U; Birner H; Stangassinger M
Calcif Tissue Int; 1997 May; 60(5):434-40. PubMed ID: 9115161
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
[TBL] [Abstract][Full Text] [Related]
14. Effects of tibolone on the development of osteopenia induced by ovariectomy in rats.
Pytlik M
Pol J Pharmacol; 2002; 54(1):35-43. PubMed ID: 12020042
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of droloxifene, tamoxifen, and estrogen on bone, serum cholesterol, and uterine histology in the ovariectomized rat model.
Ke HZ; Chen HK; Simmons HA; Qi H; Crawford DT; Pirie CM; Chidsey-Frink KL; Ma YF; Jee WS; Thompson DD
Bone; 1997 Jan; 20(1):31-9. PubMed ID: 8988345
[TBL] [Abstract][Full Text] [Related]
16. The androgenic anabolic steroid nandrolone decanoate prevents osteopenia and inhibits bone turnover in ovariectomized cynomolgus monkeys.
Jerome CP; Power RA; Obasanjo IO; Register TC; Guidry M; Carlson CS; Weaver DS
Bone; 1997 Apr; 20(4):355-64. PubMed ID: 9108356
[TBL] [Abstract][Full Text] [Related]
17. Comparative therapeutic effects of alendronate and alfacalcidol on cancellous and cortical bone mass and mechanical properties in ovariectomized osteopenic rats.
Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Yeh JK
J Nutr Sci Vitaminol (Tokyo); 2006 Feb; 52(1):1-8. PubMed ID: 16637224
[TBL] [Abstract][Full Text] [Related]
18. Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH.
Iwaniec UT; Samnegård E; Cullen DM; Kimmel DB
Bone; 2001 Oct; 29(4):352-60. PubMed ID: 11595618
[TBL] [Abstract][Full Text] [Related]
19. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
Shen V; Birchman R; Wu DD; Lindsay R
J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
[TBL] [Abstract][Full Text] [Related]
20. Tibolone, a steroid with a tissue-specific hormonal profile, completely prevents ovariectomy-induced bone loss in sexually mature rats.
Ederveen AG; Kloosterboer HJ
J Bone Miner Res; 1999 Nov; 14(11):1963-70. PubMed ID: 10571697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
